(Q43821631)

English

Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution

scientific article published on 6 December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution (English)

1 reference

Europe PubMed Central

27 November 2017

author name string

Patrice D Côté

1

1 reference

Europe PubMed Central

27 November 2017

Hakima Moukhles

2

1 reference

Europe PubMed Central

27 November 2017

Salvatore Carbonetto

3

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

6 December 2001

1 reference

Europe PubMed Central

27 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

27 November 2017

277

1 reference

Europe PubMed Central

27 November 2017

7

1 reference

Europe PubMed Central

27 November 2017

4672-4679

1 reference

Europe PubMed Central

27 November 2017

Membrane organization of the dystrophin-glycoprotein complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Glycoprotein complex anchoring dystrophin to sarcolemma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

The alpha7beta1 integrin in muscle development and disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Muscular dystrophies: alterations in a limited number of cellular pathways?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Molecular basis of muscular dystrophies.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Subcellular fractionation of dystrophin to the triads of skeletal muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Dystrophic muscle in mice chimeric for expression of alpha5 integrin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Absence of integrin alpha 7 causes a novel form of muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Caveolin-3 in muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Caveolin-3 is not an integral component of the dystrophin glycoprotein complex.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Increased caveolin-3 levels in mdx mouse muscles.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Caveolin-3 deficiency causes muscle degeneration in mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Derivation of completely cell culture-derived mice from early-passage embryonic stem cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

alpha-dystroglycan isoforms are differentially distributed in adult rat retina

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Distribution of alpha-dystroglycan during embryonic nerve-muscle synaptogenesis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Identification and characterization of the dystrophin anchoring site on beta-dystroglycan

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

An intact cysteine-rich domain is required for dystrophin function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Is the carboxyl-terminus of dystrophin required for membrane association? A novel, severe case of duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Interaction of dystrophin fragments with model membranes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Forced expression of dystrophin deletion constructs reveals structure-function correlations.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Molecular organization of sarcoglycan complex in mouse myotubes in culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

gamma-AChR/epsilon-AChR switch at agrin-induced postsynaptic-like apparatus in skeletal muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Laminin polymerization induces a receptor-cytoskeleton network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M106879200

21 January 2018

Identifiers

10.1074/JBC.M106879200

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43821631&oldid=2103652633"